PLx Pharma

Industry · 11 registered clinical trials.

Status	Trial	Phase	Started
Completed	Pharmacodynamic and Pharmacokinetic Study of PL-ASA Healthy Volunteers	Phase 4	2021-04-28
Completed	Randomized, Crossover Bioequivalence Study of PL-ASA Versus Immediate Release Aspirin in Healthy Volunteers. Bioequivalence	Phase 1	2020-05-07
Completed	Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients Diabetes Mellitus, Type 2	Phase 3	2014-01-01
Completed	Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects Gastroduodenal Ulceration	Phase 2	2012-09-01
Completed	Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients Diabetes Mellitus, Type 2	Phase 3	2012-01-01
Completed	Food-Effect Pharmacokinetic Study of PL2200 Healthy	Phase 1	2010-10-01
Completed	Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adult Gastroduodenal Ulcerations, Erosion	Phase 2	2010-07-01
Completed	Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adults Healthy Volunteers	Phase 1 / Phase 2	2009-08-01
Completed	Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healt Upper Gastrointestinal Mucosal Damage	Phase 1 / Phase 2	2009-01-01
Completed	Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex Bioequivalence	Phase 1	2008-02-11
Completed	Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial Osteoarthritis	Phase 2	2005-01-01